SLNO logo

Soleno Therapeutics, Inc. Common Stock


SLNO: Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.


Show SLNO Financials

Consumer Interest
SEC Filings

Recent trades of SLNO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by SLNO's directors and management

Government lobbying spending instances

  • $40,000 Jul 19, 2023 Issue: Pharmacy
  • $20,000 Apr 20, 2023 Issue: Pharmacy
U.S. Patents

New patents grants

  • Patent Title: Resuscitation bag Jul. 20, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of SLNO in WallStreetBets Daily Discussion


Recent insights relating to SLNO

CNBC Recommendations

Recent picks made for SLNO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLNO

Corporate Flights

Flights by private jets registered to SLNO